William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage ...

O4, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

After a weak first half, the drug and biotech sector regained momentum in the latter part of 2025, setting the stage for a ...

Philadelphia has lagged in biotech R&D jobs despite University of Pennsylvania scientists playing a leading role in ...

In The Star's annual year in review, the county's biggest business stories included housing proposals and the aftermath of a ...

One of the biotech industry’s most esteemed venture capitalists anticipates that, after two years of drought, a wave of drug ...

Abivax (ABVX) stock leads biotech M&A prospects for 2026 while Madrigal Pharmaceuticals (MDGL) trails, according to a survey ...

Choose San Francisco Business Times as a preferred news source to see more of our reporting on Google.

Geron Corporation, a Bay Area biotech company that’s ramping up sales of its first commercial drug, announced on Thursday ...

Adding another potential wrinkle to the industry’s work with China is the Biosecure Act, a piece of China-targeting national ...

TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA(1) positive operations in Q3 2025 and expects to achieve strong ...